This topic contains a solution. Click here to go to the answer

Author Question: A probable reason why the Abecedarian Project had stronger positive effects than Head Start is that ... (Read 64 times)

big1devin

  • Hero Member
  • *****
  • Posts: 583
A probable reason why the Abecedarian Project had stronger positive effects than Head Start is that it had
 
  a. many years as a federally-funded project, which gave time for improvement.
   b. an intensive design with many hours of intervention combined with home visits.
   c. a curriculum that emphasized standardized tests.
 
   d. more teachers of color involved.

Question 2

Compared to control groups, longitudinal studies of the effectiveness of Head Start have shown that Head Start students
 
  a. showed more learning disabilities.
 
   b. showed modest cognitive gains.
 
   c. showed large cognitive gains.
 
   d. had lowered occupational aspirations while in high school.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Mollythedog

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

ANSWER: b

Answer to Question 2

ANSWER: b




big1devin

  • Member
  • Posts: 583
Reply 2 on: Sep 15, 2018
Great answer, keep it coming :)


dreamfighter72

  • Member
  • Posts: 355
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

Limit intake of red meat and dairy products made with whole milk. Choose skim milk, low-fat or fat-free dairy products. Limit fried food. Use healthy oils when cooking.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library